This page shows the latest MK-3102 news and features for those working in and with pharma, biotech and healthcare.
Merck also has a Januvia follow-up in development, with phase IIb data suggesting that MK-3102 could offer a similar level of effectiveness, but at a once-weekly rather than
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...